Tenax Therapeutics (NASDAQ:TENX) Earns “Outperform” Rating from William Blair
Tenax Therapeutics (NASDAQ:TENX – Get Free Report)‘s stock had its “outperform” rating restated by research analysts at William Blair in a report released on Monday,RTT News reports. Separately, Leerink Partners set a $20.00 price target on Tenax Therapeutics in a research report on Monday. One research analyst has rated the stock with a sell rating, […]
Tenax Therapeutics (NASDAQ:TENX – Get Free Report)‘s stock had its “outperform” rating restated by research analysts at William Blair in a report released on Monday,RTT News reports. Separately, Leerink Partners set a $20.00 price target on Tenax Therapeutics in a research report on Monday. One research analyst has rated the stock with a sell rating, […]
